Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, China Resources Zizhu Pharmaceutical Co., Ltd. (“China Resources Zizhu”), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” for propranolol hydrochloride injections issued by the State Drug Administration. After review, a supplementary application for adding the 2ml:2mg specification to this product was approved, and a drug approval number was issued. This product passed the consistent evaluation of the quality and efficacy of generic drugs.

Zhitongcaijing · 2d ago
Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, China Resources Zizhu Pharmaceutical Co., Ltd. (“China Resources Zizhu”), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” for propranolol hydrochloride injections issued by the State Drug Administration. After review, a supplementary application for adding the 2ml:2mg specification to this product was approved, and a drug approval number was issued. This product passed the consistent evaluation of the quality and efficacy of generic drugs.